Scynexis (SCYX) Preferred Dividend Payments (2013 - 2014)
Scynexis (SCYX) posted Preferred Dividend Payments of -$1.1 million for Q4 2014, down 528.63% on a QoQ basis from $262000.0 in Q2 2014, and up 80.35% year-over-year from -$622690.2 in Q4 2013.
Scynexis (SCYX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Scynexis' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at -$1.1 million for Q4 2014.
- Quarterly Preferred Dividend Payments rose 80.35% year-over-year to -$1.1 million in Q4 2014, while the trailing twelve-month figure through Sep 2015 was -$1.1 million (up 77.28% YoY) and the FY2014 annual result came in at $510000.0, up 108.93% from the prior year.
- Preferred Dividend Payments was -$1.1 million for Q4 2014 at Scynexis, down from $262000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $510000.0 in Q1 2014 and bottomed at -$5.7 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.12 Mn |
| Jun 30, 2014 | 262,000.00 |
| Mar 31, 2014 | 510,000.00 |
| Dec 31, 2013 | -5.71 Mn |